Condition
Malignant Mesothelioma
Estimated Enrollment: 47
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Case-Only|Time Perspective: Prospective
Study ID Numbers: CALGB-150509|U10CA031946|CDR0000491313
Study First Received: May 9, 2009
Last Updated: July 1, 2016
Estimated Primary Completion Date: March 2006
Primary Outcome Measures:
Level of biomarkers, including thrombospondin I, vascular endothelial growth factor receptor I, fibroblast growth factor, transforming growth factor, and mesothelin (high vs low)|Effect of biomarker expression level on overall survival
Sponsors and Collaborators:
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00898547
